240 related articles for article (PubMed ID: 27224631)
1. Polypharmacy: the challenge for nurses.
Kaufman G
Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
[TBL] [Abstract][Full Text] [Related]
2. Multimorbidity and Frailty: Tackling Complexity in Parkinson's Disease.
Tenison E; Henderson EJ
J Parkinsons Dis; 2020; 10(s1):S85-S91. PubMed ID: 32741841
[TBL] [Abstract][Full Text] [Related]
3. Benefits of deprescribing for older people with frailty and polypharmacy: part one.
Lyne S
Nurs Older People; 2023 Oct; 35(5):35-41. PubMed ID: 37670533
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy stewardship: a novel approach to tackle a major public health crisis.
Daunt R; Curtin D; O'Mahony D
Lancet Healthy Longev; 2023 May; 4(5):e228-e235. PubMed ID: 37030320
[TBL] [Abstract][Full Text] [Related]
5. A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people.
Stewart D; Gibson-Smith K; MacLure K; Mair A; Alonso A; Codina C; Cittadini A; Fernandez-Llimos F; Fleming G; Gennimata D; Gillespie U; Harrison C; Junius-Walker U; Kardas P; Kempen T; Kinnear M; Lewek P; Malva J; McIntosh J; Scullin C; Wiese B
PLoS One; 2017; 12(11):e0188348. PubMed ID: 29155870
[TBL] [Abstract][Full Text] [Related]
6. [Management of polypharmacy in older people with multimorbidity].
Hoffmann U
Inn Med (Heidelb); 2024 Jan; 65(1):9-16. PubMed ID: 38059997
[TBL] [Abstract][Full Text] [Related]
7. The challenge of HIV treatment in an era of polypharmacy.
Back D; Marzolini C
J Int AIDS Soc; 2020 Feb; 23(2):e25449. PubMed ID: 32011104
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of polypharmacy.
Payne RA
Clin Med (Lond); 2016 Oct; 16(5):465-469. PubMed ID: 27697812
[TBL] [Abstract][Full Text] [Related]
9. The need for a prescribing competency framework to address the burden of complex polypharmacy among multiple long-term conditions.
Picton C; Loughrey C; Webb A
Clin Med (Lond); 2016 Oct; 16(5):470-474. PubMed ID: 27697813
[TBL] [Abstract][Full Text] [Related]
10. Understanding the pharmacology of the side effects of medicines for effective prevention of adverse drug reactions.
Coulson J
Nurs Stand; 2022 Mar; 37(3):37-43. PubMed ID: 34913303
[TBL] [Abstract][Full Text] [Related]
11. [Polypharmacy in acute and chronic kidney diseases].
Manaila R; Huwiler A
Inn Med (Heidelb); 2024 Jan; 65(1):22-28. PubMed ID: 38110759
[TBL] [Abstract][Full Text] [Related]
12. Use of a medication passport in a disabled child seen across many care settings.
Jubraj B; Blair M
BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25716039
[TBL] [Abstract][Full Text] [Related]
13. What types of inappropriate prescribing predict adverse drug reactions in older adults?
Hanlon JT; Schmader KE
Ann Pharmacother; 2010 Jun; 44(6):1110-1. PubMed ID: 20460555
[TBL] [Abstract][Full Text] [Related]
14. Screening indicators to evaluate the clinical significance of drug-drug interactions in polypharmacy among older adults with psychiatric disorders: a delphi study.
Liu Y; Li X; Yang M; Ding Y; Ji M
BMC Psychiatry; 2024 Jun; 24(1):417. PubMed ID: 38834965
[TBL] [Abstract][Full Text] [Related]
15. Benefits of deprescribing for older people with frailty and polypharmacy: part two.
Lyne S
Nurs Older People; 2023 Sep; ():. PubMed ID: 37726987
[TBL] [Abstract][Full Text] [Related]
16. Prescribing medicines to older people-How to consider the impact of ageing on human organ and body functions.
Drenth-van Maanen AC; Wilting I; Jansen PAF
Br J Clin Pharmacol; 2020 Oct; 86(10):1921-1930. PubMed ID: 31425638
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Andelius DK; Jessen NH; Løkke A; Nielsen RØ; Jacobsen JS
Ugeskr Laeger; 2023 Oct; 185(42):. PubMed ID: 37897377
[TBL] [Abstract][Full Text] [Related]
18. A survey on polypharmacy and use of inappropriate medications.
Rambhade S; Chakarborty A; Shrivastava A; Patil UK; Rambhade A
Toxicol Int; 2012 Jan; 19(1):68-73. PubMed ID: 22736907
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy as Formal Training and a Model of Practice.
Schuh MJ; Crosby SK
Sr Care Pharm; 2024 May; 39(5):173-177. PubMed ID: 38685622
[TBL] [Abstract][Full Text] [Related]
20. Person-centred medicines optimisation policy in England: an agenda for research on polypharmacy.
Heaton J; Britten N; Krska J; Reeve J
Prim Health Care Res Dev; 2017 Jan; 18(1):24-34. PubMed ID: 27306579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
